Matthew Link

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Link:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sight Sciences, Inc. Chief Commercial Officer Common Stock 832K $3.41M $4.10 Jul 2, 2025 Direct
FibroBiologics, Inc. Director Stock Option (Right to Buy) 22K Jun 12, 2025 Direct

Insider Reports Filed by Matthew Link

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGHT Sight Sciences, Inc. Aug 31, 2025 0 $0 4 Sep 3, 2025 Chief Commercial Officer
SGHT Sight Sciences, Inc. Jul 2, 2025 1 -$20K 4 Jul 7, 2025 Chief Commercial Officer
FBLG FibroBiologics, Inc. Jun 12, 2025 1 $0 4 Jun 12, 2025 Director
SGHT Sight Sciences, Inc. May 16, 2025 1 $20K 4 May 21, 2025 Chief Commercial Officer
SGHT Sight Sciences, Inc. Apr 2, 2025 1 -$11.6K 4 Apr 3, 2025 Chief Commercial Officer
SGHT Sight Sciences, Inc. Mar 11, 2025 1 $0 4 Mar 13, 2025 Chief Commercial Officer
SGHT Sight Sciences, Inc. Oct 18, 2024 2 -$245K 4 Oct 21, 2024 Chief Commercial Officer
SGHT Sight Sciences, Inc. Oct 16, 2024 2 -$245K 4 Oct 18, 2024 Chief Commercial Officer
FBLG FibroBiologics, Inc. Aug 27, 2024 1 $0 4 Aug 27, 2024 Director
FBLG FibroBiologics, Inc. Jan 24, 2024 0 $0 3/A Aug 13, 2024 Director
FBLG FibroBiologics Inc. Jan 24, 2024 0 $0 3 Feb 13, 2024 Director
SGHT Sight Sciences, Inc. Nov 14, 2023 2 $0 4 Nov 16, 2023 Chief Commercial Officer
SGHT Sight Sciences, Inc. Sep 11, 2023 0 $0 3 Sep 12, 2023 Chief Commercial Officer